Metabolon Signs Collaboration with Army Medical Research Institute

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Metabolon, Inc., the leader in metabolomics-driven biomarker discovery, announced today the signing of a contract supporting the US Army Medical Research Institute of Infectious Diseases (USAMRIID). The collaboration uses Metabolon’s proprietary metabolomics platform to study the biochemical profiles of humans given the AVA anthrax vaccine. The AVA vaccine is the only FDA-licensed anthrax vaccine for humans.

Back to news